Burton E. Sobel

Active 1966–2012

Also published as
BURTON E. SOBEL
176
Papers
32,259
Citations
114
h-index
176
i10-index

Citations

Citations per year for Burton E. Sobel1967: 2 citations1968: 3 citations1969: 4 citations1970: 3 citations1971: 10 citations1972: 33 citations1973: 62 citations1974: 70 citations1975: 137 citations1976: 99 citations1977: 100 citations1978: 117 citations1979: 82 citations1980: 81 citations1981: 112 citations1982: 108 citations1983: 119 citations1984: 144 citations1985: 202 citations1986: 146 citations1987: 141 citations1988: 109 citations1989: 176 citations1990: 134 citations1991: 102 citations1992: 141 citations1993: 152 citations1994: 119 citations1995: 143 citations1996: 153 citations1997: 131 citations1998: 160 citations1999: 155 citations2000: 149 citations2001: 180 citations2002: 158 citations2003: 183 citations2004: 182 citations2005: 147 citations2006: 143 citations2007: 143 citations2008: 105 citations2009: 106 citations2010: 83 citations2011: 87 citations2012: 96 citations2013: 84 citations2014: 50 citations2015: 74 citations2016: 61 citations2017: 47 citations2018: 43 citations2019: 127 citations2020: 154 citations2021: 117 citations2022: 97 citations2023: 86 citations2024: 94 citations2025: 39 citations2026: 1 citations

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,492 citing papers, 43.8% of this breakdownUnited Kingdom: 400 citing papers, 7% of this breakdownGermany: 281 citing papers, 4.9% of this breakdownCanada: 256 citing papers, 4.5% of this breakdownItaly: 254 citing papers, 4.5% of this breakdownNetherlands: 174 citing papers, 3.1% of this breakdownJapan: 169 citing papers, 3% of this breakdownChina: 168 citing papers, 3% of this breakdownFrance: 144 citing papers, 2.5% of this breakdownAustralia: 127 citing papers, 2.2% of this breakdownSpain: 105 citing papers, 1.8% of this breakdownSweden: 80 citing papers, 1.4% of this breakdown
0%43.8%Other 18.3%

Fields

  • Medicine74.2%
  • Biochemistry, Genetics and Molecular Biology14%
  • Neuroscience3.9%
  • Engineering1.6%
  • Environmental Science1.3%
  • Immunology and Microbiology1.3%
  • Other3.7%

Topics

  • Cardiac Imaging and Diagnostics5.6%
  • Acute Myocardial Infarction Research4.7%
  • Cardiac electrophysiology and arrhythmias3.4%
  • Cardiovascular Function and Risk Factors3.4%
  • Cardiac Ischemia and Reperfusion2.9%
  • Coronary Interventions and Diagnostics2.2%
  • Other77.8%

Coauthors

All papers

Open in search
  1. Circadian Variation in the Frequency of Onset of Acute Myocardial Infarction

    Authors: , , , , , , , , , , , , , - New England Journal of Medicine 1985 cited by 1,875

  2. Multipotent human stromal cells improve cardiac function after myocardial infarction in mice without long-term engraftment

    Authors: , , , , , , , , - Biochemical and Biophysical Research Communications 2007 cited by 404

  3. Morphological and cytochemical determination of cell death by apoptosis

    Authors: , , - Histochemistry and Cell Biology 2007 cited by 232

  4. Effects of increased concentrations of glucose on platelet reactivity in healthy subjects and in patients with and without diabetes mellitus

    Authors: , , - The American Journal of Cardiology 2003 cited by 155

  5. Mitochondrial dysfunction induced by fatty acid ethyl esters, myocardial metabolites of ethanol.

    Authors: , - Journal of Clinical Investigation 1983 cited by 249

  6. Reduction of Experimental Myocardial Infarct Size by Corticosteroid Administration

    Authors: , , , , - Journal of Clinical Investigation 1973 cited by 291

  7. Quantification of regional myocardial blood flow in vivo with H215O.

    Authors: , , , , , , - Circulation 1984 cited by 368

  8. Prognostic significance of location and type of myocardial infarction: Independent adverse outcome associated with anterior location

    Authors: , , , , , , , , , , , , - Journal of the American College of Cardiology 1988 cited by 253

  9. Double-Blind, Randomized Trial of an Anti-CD18 Antibody in Conjunction With Recombinant Tissue Plasminogen Activator for Acute Myocardial Infarction

    Authors: , , , , , , , , , , , , - Circulation 2001 cited by 206

  10. Factors Influencing Infarct Size Following Experimental Coronary Artery Occlusions

    Authors: , , , , , , - Circulation 1971 cited by 1,483

  11. Increased myocardial perfusion at rest and diminished perfusion reserve in patients with angina and angiographically normal coronary arteries

    Authors: , , , , - Journal of the American College of Cardiology 1990 cited by 200

  12. Differential Effects of Anticoagulants on the Activation of Platelets Ex Vivo

    Authors: , , , - Circulation 1997 cited by 114

  13. Coronary Artery Reperfusion

    Authors: , , , , , , - Journal of Clinical Investigation 1972 cited by 372

  14. Coronary Artery Reperfusion

    Authors: , , , , , - Journal of Clinical Investigation 1972 cited by 286

  15. Induction of Plasminogen Activator Inhibitor Type-1 (PAI-1) by Proinsulin and Insulin In Vivo

    Authors: , , , - Circulation 1995 cited by 186

  16. Anisotropy of the ultrasonic backscatter of myocardial tissue: II. Measurements i n v i v o

    Authors: , , , , - The Journal of the Acoustical Society of America 1988 cited by 128

  17. Post-transcriptional regulation of expression of plasminogen activator inhibitor type 1 mRNA by insulin and insulin-like growth factor 1.

    Authors: , , , - Journal of Biological Chemistry 1992 cited by 103

  18. Inhibition of apoptosis and caspase‐3 in vascular smooth muscle cells by plasminogen activator inhibitor type‐1

    Authors: , , , , - Journal of Cellular Biochemistry 2004 cited by 92

  19. Augmentation of Proliferation of Vascular Smooth Muscle Cells by Plasminogen Activator Inhibitor Type 1

    Authors: , , , , - Arteriosclerosis Thrombosis and Vascular Biology 2006 cited by 81

  20. Normal Oxidative Phosphorylation in Mitochondria from the Failing Heart

    Authors: , , , , - Circulation Research 1967 cited by 81

  21. Summary of the second report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II)

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , - JAMA 1993 cited by 458

  22. Troglitazone Improves Defects in Insulin Action, Insulin Secretion, Ovarian Steroidogenesis, and Fibrinolysis in Women with Polycystic Ovary Syndrome1

    Authors: , , , , , , - The Journal of Clinical Endocrinology & Metabolism 1997 cited by 453

  23. Coronary thrombolysis with recombinant human tissue-type plasminogen activator: a prospective, randomized, placebo-controlled trial.

    Authors: , , , , , , , , , - Circulation 1984 cited by 385

  24. Coronary Thrombolysis with Tissue-Type Plasminogen Activator in Patients with Evolving Myocardial Infarction

    Authors: , , , , , , , , - New England Journal of Medicine 1984 cited by 361